Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

BACKGROUND: Varenicline, a new treatment for smoking cessation, has demonstrated significantly greater efficacy over placebo and sustained release bupropion (bupropion SR). A study was undertaken to compare a 12-week standard regimen of varenicline with a 10-week standard regimen of transdermal nico...

Descripción completa

Detalles Bibliográficos
Autores principales: Aubin, H-J, Bobak, A, Britton, J R, Oncken, C, Billing, C B, Gong, J, Williams, K E, Reeves, K R
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2008
Materias:
Smoking
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2569194/
https://www.ncbi.nlm.nih.gov/pubmed/18263663
http://dx.doi.org/10.1136/thx.2007.090647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2569194/
https://www.ncbi.nlm.nih.gov/pubmed/18263663
http://dx.doi.org/10.1136/thx.2007.090647

Ejemplares similares